Thursday, November 28, 2013

Biosensors International : Sale by largest shareholder (OCBC)

Biosensors International Group:
Fair value S$0.80
add: 12m dividend forecast S$0.025
versus: Current price S$0.98
Sale by largest shareholder

Shandong Weigao (SW), which is Biosensors International Group’s (BIG) largest shareholder, announced that it has agreed to dispose its entire 21.7% stake in BIG to CB Medical Holdings Limited (CBMH) at a sale price of S$1.05 per share. According to a SGX-net filing, CBMH is part of CITIC Private Equity Funds Management, a large private equity fund in China. As SW will incur a loss of ~CNY449.0m from this transaction, we believe it also partly reflects the lack of confidence in BIG’s prospects going forward. We do not foresee any impact from SW’s sale on the operations of BIG. While we do not rule out the possibility of a privatisation exercise on BIG by CBMH in the future, we continue to value the stock based on our expectations of its operational performance. Hence, maintain SELL and S$0.80 fair value estimate on BIG.


Shandong Weigao to sell its entire 21.7% stake in BIG
Shandong Weigao (SW), which is Biosensors International Group’s (BIG) single largest shareholder, announced that it has entered into a Sale and Purchase Agreement to dispose its entire 21.7% stake in BIG to CB Medical Holdings Limited (CBMH). The total aggregate consideration of US$312.3m translates into a purchase price of S$1.05 per share by CBMH. This represents a 11.2% premium to BIG’s closing price prior to this announcement. CBMH is an investment holding company incorporated in Bermuda. According to a SGX-net filing, it is part of CITIC Private Equity Funds Management, a large private equity fund in China. SW cited the increasingly competitive business environment in China and its decision to focus on its three core business units in which it has controlling equity interests as its reasons for disposing its stake in BIG. As SW will incur a loss of ~CNY449.0m from this transaction, we believe it also partly reflects the lack of confidence in BIG’s prospects going forward.

Transaction unlikely to impact BIG’s operations
We do not foresee any impact from SW’s sale on the operations of BIG. While both companies have healthcare operations in China, BIG has operated independently from SW even when SW became a shareholder of BIG. This is because BIG has its own established manufacturing facilities, distribution channels and networks in China. SW also does not compete with BIG, nor is it a supplier or customer of BIG.

Valuations rich; maintain SELL
While we do not rule out the possibility of a privatisation exercise on BIG by CBMH in the future, we continue to value the stock based on our expectations of its operational performance. Hence, with our estimates kept intact, we maintain our SELL rating and S$0.80 fair value estimate on BIG. Given the recent hike in BIG’s share price and with BIG now trading at a rich valuation of 20.7x blended FY14/15F PER, we believe it is an opportune time for investors to lock in some profits.


Source/Extract/Excerpts/来源/转贴/摘录: OCBC-Research,
Publish date: 25/11/13

No comments:

Post a Comment

Warren E. Buffett(沃伦•巴菲特)
Be fearful when others are greedy, and be greedy when others are fearful
别人贪婪时我恐惧, 别人恐惧时我贪婪
投资只需学好两门课: 一,是如何给企业估值,二,是如何看待股市波动
吉姆·罗杰斯(Jim Rogers)
“错过时机”胜于“搞错对象”:不会全军覆没!”
做自己熟悉的事,等到发现大好机会才投钱下去

乔治·索罗斯(George Soros)

“犯错误并没有什么好羞耻的,只有知错不改才是耻辱。”

如果操作过量,即使对市场判断正确,仍会一败涂地。

李驰(中国巴菲特)
高估期间, 卖对, 不卖也对, 买是错的。
低估期间, 买对, 不买也是对, 卖是错的。

Tan Teng Boo


There’s no such thing as defensive stocks.Every stock can be defensive depending on what price you pay for it and what value you get,
冷眼(冯时能)投资概念
“买股票就是买公司的股份,买股份就是与陌生人合股做生意”。
合股做生意,则公司股份的业绩高于一切,而股票的价值决定于盈利。
价值是本,价格是末,故公司比股市重要百倍。
曹仁超-香港股神/港股明灯
1.有智慧,不如趁势
2.止损不止盈
成功者所以成功,是因为不怕失败!失败者所以失败,是失败后不再尝试!
曾淵滄-散户明灯
每逢灾难就是机会,而是在灾难发生时贱价买股票,然后放在一边,耐性地等灾难结束
  • Selected Indexes 52 week range

  • Margin of Safety

    Investment Clock

    World's First Interactive Investment Clock